Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€21.80

€21.80

0.920%
0.2
0.920%
€93.50

€93.50

 
22.12.25 / Tradegate WKN: A2ATUH / Symbol: XOMA / Name: XOMA / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
12.12.25
0.93%
buy
€38.50
11.12.25
-4.39%
buy
11.12.25
-4.39%
buy
12.09.25
-31.88%
buy
14.06.25
5.00%
buy
31.05.25
1.87%
buy
Your prediction

XOMA Corp. Stock

The XOMA Corp. stock is trending slightly upwards today, with an increase of €0.20 (0.920%) compared to yesterday's price.
With 11 Buy predictions and not the single Sell prediction the community is currently very high on XOMA Corp..
With a target price of 93 € there is potential for a 326.61% increase which would mean more than doubling the current price of 21.8 € for XOMA Corp..
So far the community has only identified positive things for XOMA Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of XOMA Corp. in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

XOMA Royalty (NASDAQ:XOMA) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Ratings data for XOMA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -4.39%
Target price 38.498
Change
Ends at 11.12.26

XOMA Royalty (NASDAQ:XOMA) was given a new $45.00 price target on by analysts at Leerink Partners. They now have an "outperform" rating on the stock.
Ratings data for XOMA provided by MarketBeat
Show more

XOMA Royalty (NASDAQ:XOMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ratings data for XOMA provided by MarketBeat
Show more

News

XOMA Revenue Jumps 39% in Fiscal Q2
XOMA Revenue Jumps 39% in Fiscal Q2

XOMA (NASDAQ:XOMA), a biotechnology royalty aggregator, reported second quarter results on August 13, 2025, for the period ending June 30. The company’s revenue (GAAP) reached $13.1 million for Q2